Register your interest

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring below you consent to us contacting you via these methods.

 

One of the strongest enterprise investment scheme offers you will see in 2019

Eden Pharma allows investors access a unique market which is completely new to the UK. The company is currently in the process of offering 9.4% of the company's equity at a pre-sale value of £8.15 million through an EIS placement that will raise £850,000. The proceeds are to be used for land acquisition for cannabis cultivation as well as further investment in R&D and IP protection.

WHY INVEST IN MEDICAL CANNABIS?

  Widely thought to be the fastest growing industry in the world
  Today, the global cannabis market is thought to be worth $150 billion. Barclays' 2018 European Consumer Staples Report estimates that this figure could increase to $272 billion by 2028.
  The list of potential uses, and medical treatments is very broad, but the scientific work still needs to be done
  Big Pharma are largely staying out of the legal cannabis which creates a huge opportunity for cannabis specific companies
DISCLAIMER: This email has been sent to you on the basis that you are reasonably believed to be such a person as is described in Article 19 (Investment professionals), Article 48 (Certified high net worth individuals), Article 49 (High net worth companies, unincorporated associations etc.), Article 50 (Sophisticated investors), Article 50A (Self-certified sophisticated investors) and Article 51 (Associations of high net worth or sophisticated investors) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or you are a person to whom this email may otherwise lawfully be sent. If you do not fall within such descriptions, then you should not act upon the information contained in this email.